Department of Infectious Diseases and Clinical Microbiology, Kayseri Health Practice and Research Center, University of Health Sciences, Kayseri, Turkey
Department of Clinical Microbiology, Kayseri Health Practice and Research Center, University of Health Sciences, Kayseri, Turkey
Turk J Med Sci. 2020 Apr 21;50(SI-1):557-562. doi: 10.3906/sag-2004-126.
Infectious diseases remain as the significant causes of human and animal morbidity and mortality, leading to extensive outbreaks and epidemics. Acute respiratory viral diseases claim over 4 million deaths and cause millions of hospitalizations in developing countries every year. Emerging viruses, especially the RNA viruses, are more pathogenic since most people have no herd immunity. The RNA viruses can adapt to the rapidly changing global and local environment due to the high error rate of their polymerases that replicate their genomes. Currently, coronavirus disease 2019 (COVID-19) is determined as an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first identified in 2019 in Wuhan. Herein we discuss emerging and reemerging respiratory viral infections till to SARS-CoV-2.
传染病仍然是人类和动物发病和死亡的重要原因,导致广泛的爆发和流行。急性呼吸道病毒疾病每年导致发展中国家超过 400 万人死亡,并导致数百万人住院。新兴病毒,特别是 RNA 病毒,由于大多数人没有群体免疫,因此具有更高的致病性。由于其复制基因组的聚合酶错误率很高,RNA 病毒能够适应快速变化的全球和本地环境。目前,2019 年冠状病毒病(COVID-19)被确定为由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的传染病,该病毒于 2019 年在中国武汉首次被发现。在此,我们讨论了直至 SARS-CoV-2 的新发和再发呼吸道病毒感染。